AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

SUGAMMADEX 200 Mg ;

9 registrations across 1 African market— 9 active

Markets with SUGAMMADEX 200 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
sugammadex-Sunny Pharmaceutical
solution for intravenous injection
🇪🇬EgyptSUNNY PHARMACEUTICAL-EGYPTactive
Sugammadex Biofactor
solution for intravenous injection
🇪🇬EgyptPharmacon for Importationactive
Bridion®
solution for intravenous injection
🇪🇬EgyptMERCK SHARP&DOHME SCIENTIFIC OFFICEactive
sugammadex-Sunny Pharmaceutical
solution for intravenous injection
🇪🇬EgyptSUNNY PHARMACEUTICAL-EGYPTactive
Neurosugam 200 mg/2 ml
solution for intravenous injection
🇪🇬Egyptal andalous for pharmaceutical industriesactive
Bridion®
solution for intravenous injection
🇪🇬EgyptMERCK SHARP&DOHME SCIENTIFIC OFFICEactive
Sugammadex Biofactor
solution for intravenous injection
🇪🇬EgyptPharmacon for Importationactive
Neurosugam 200 mg/2 ml
solution for intravenous injection
🇪🇬Egyptal andalous for pharmaceutical industriesactive
Bridion®
solution for intravenous injection
🇪🇬EgyptMERCK SHARP and DOHME SCIENTIFIC OFFICEactive

SUGAMMADEX 200 Mg ; in Africa — Regulatory Overview

SUGAMMADEX 200 Mg ; is registered across 1 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 9 registrations, 9 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.